ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Phreesia Named in Black Book Research’s List of 2025’s Top-Rated Vendors for Patient Access and Front-End Management Solutions in Revenue Cycle Management

Phreesia, a leader in patient intake, outreach and activation, has been named to Black Book Research’s 2025 list of Top-Rated Vendors for Patient Access and Front-End Management Solutions in Revenue Cycle Management (RCM). The awards program is based on survey responses collected from 11,500+ healthcare finance professionals, administrators and RCM specialists. Phreesia was selected as the 2025 Top-Rated Vendor for Patient Registration and Intake Solutions for Ambulatory and Physician Practices.

"It’s an honor to be named a top-rated vendor by Black Book Research,” said Phreesia CEO Chaim Indig. “Our solutions help healthcare organizations overcome RCM challenges while also driving stronger financial performance and patient satisfaction, and it's rewarding to be recognized for those efforts.”

In the annual survey, nearly 89% of respondents reported that delays or inaccuracies in front-end processes had a direct impact on cash flow, denied claims and patient satisfaction in 2024. Additionally, 77% of provider organizations reported increasing their investments in automation tools specifically for patient access and insurance eligibility verification, up from 63% in 2023, showing an increased demand for digital RCM tools.

"Efficient patient access and front-end management processes are foundational to revenue cycle success," said Doug Brown, Founder of Black Book Research. "This year's top vendors distinguished themselves through outstanding performance in automation, accuracy and ease of integration, delivering measurable financial outcomes and improved patient experiences."

Black Book Research is an independent healthcare technology research firm. Its annual survey evaluated vendors across three core categories critical to optimizing revenue cycle performance: financial clearance and eligibility, insurance verification, and patient registration and intake solutions. Separate evaluations were conducted for inpatient facilities and hospitals, and ambulatory and physician practices, highlighting distinct needs and solutions within these settings.

For more information on Phreesia, visit www.phreesia.com.

About Phreesia

Phreesia is the trusted leader in patient activation, giving healthcare providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled approximately 170 million patient visits in 2024—1 in 7 visits across the U.S.—scale that we believe allows us to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  234.42
+0.00 (0.00%)
AAPL  286.19
+0.00 (0.00%)
AMD  215.24
+0.00 (0.00%)
BAC  53.19
+0.00 (0.00%)
GOOG  316.02
+0.00 (0.00%)
META  647.10
+0.00 (0.00%)
MSFT  490.00
+0.00 (0.00%)
NVDA  181.46
+0.00 (0.00%)
ORCL  201.10
+0.00 (0.00%)
TSLA  429.24
+0.00 (0.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.